Cargando…
Developing drugs against essential proteins of SARS-CoV-2 for the treatment of COVID-19
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Biophysical Society. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833095/ http://dx.doi.org/10.1016/j.bpj.2021.11.2667 |
| _version_ | 1784648852131807232 |
|---|---|
| author | Bajaj, Teena |
| author_facet | Bajaj, Teena |
| author_sort | Bajaj, Teena |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8833095 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Biophysical Society. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88330952022-02-14 Developing drugs against essential proteins of SARS-CoV-2 for the treatment of COVID-19 Bajaj, Teena Biophys J Article Biophysical Society. Published by Elsevier Inc. 2022-02-11 2022-02-11 /pmc/articles/PMC8833095/ http://dx.doi.org/10.1016/j.bpj.2021.11.2667 Text en Copyright © 2021 Biophysical Society. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Bajaj, Teena Developing drugs against essential proteins of SARS-CoV-2 for the treatment of COVID-19 |
| title | Developing drugs against essential proteins of SARS-CoV-2 for the treatment of COVID-19 |
| title_full | Developing drugs against essential proteins of SARS-CoV-2 for the treatment of COVID-19 |
| title_fullStr | Developing drugs against essential proteins of SARS-CoV-2 for the treatment of COVID-19 |
| title_full_unstemmed | Developing drugs against essential proteins of SARS-CoV-2 for the treatment of COVID-19 |
| title_short | Developing drugs against essential proteins of SARS-CoV-2 for the treatment of COVID-19 |
| title_sort | developing drugs against essential proteins of sars-cov-2 for the treatment of covid-19 |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833095/ http://dx.doi.org/10.1016/j.bpj.2021.11.2667 |
| work_keys_str_mv | AT bajajteena developingdrugsagainstessentialproteinsofsarscov2forthetreatmentofcovid19 |